3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Pathology

Internal Medicine

Endocrinology

Endocrinology, Diabetes And Metabolism

Show all topics

DOI

10.1016/s0140-6736(17)30069-7

Other Formats

PDF